IMA Advisory Services’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,660
Closed -$221K 342
2024
Q4
$221K Sell
19,660
-12,897
-40% -$227K 0.03% 166
2024
Q3
$921K Sell
32,557
-3,952
-11% -$102K 0.2% 101
2024
Q2
$698K Sell
36,509
-1,084
-3% -$27.7K 0.31% 63
2024
Q1
$1.23M Sell
37,593
-1,753
-4% -$55.9K 0.58% 53
2023
Q4
$1.3M Sell
39,346
-4,256
-10% -$120K 0.65% 46
2023
Q3
$1.19M Sell
43,602
-23,452
-35% -$652K 0.31% 81
2023
Q2
$2.03M Sell
67,054
-150
-0.2% -$4.85K 0.52% 60
2023
Q1
$2.18M Sell
67,204
-15,198
-18% -$481K 0.56% 55
2022
Q4
$2.31M Sell
82,402
-5,176
-6% -$148K 0.61% 50
2022
Q3
$3.15M Sell
87,578
-5,367
-6% -$189K 0.85% 32
2022
Q2
$2.85M Sell
92,945
-9,628
-9% -$281K 0.7% 42
2022
Q1
$3.31M Sell
102,573
-26,007
-20% -$681K 0.76% 35
2021
Q4
$3.56M Sell
128,580
-5,221
-4% -$150K 0.79% 38
2021
Q3
$4.15M Sell
133,801
-44,931
-25% -$1.08M 0.98% 25
2021
Q2
$3.77M Sell
178,732
-30,652
-15% -$614K 0.88% 28
2021
Q1
$4.23M Buy
209,384
+11,045
+6% +$210K 1.04% 24
2020
Q4
$3.18M Buy
198,339
+23,683
+14% +$313K 0.89% 37
2020
Q3
$2.17M Sell
174,656
-37,275
-18% -$438K 0.73% 47
2020
Q2
$1.51M Sell
211,931
-147,485
-41% -$988K 0.55% 65
2020
Q1
$1.95M Sell
359,416
-17,506
-5% -$156K 0.86% 40
2019
Q4
$3.41M Sell
376,922
-1,186
-0.3% -$9.63K 1.27% 24
2019
Q3
$2.72M Buy
378,108
+128,367
+51% +$921K 1.03% 36
2019
Q2
$1.99M Buy
249,741
+10,015
+4% +$119K 0.74% 61
2019
Q1
$3.02M Buy
239,726
+86,871
+57% +$1.38M 1.17% 29
2018
Q4
$3.05M Buy
152,855
+10,213
+7% +$236K 1.42% 17
2018
Q3
$4.05M Buy
142,642
+14,967
+12% +$357K 1.58% 16
2018
Q2
$2.69M Buy
+127,675
New +$2.42M 1.12% 30

Other funds holding EVH

IMA Advisory Services's EVH Position: Q1 2025 in Review

IMA Advisory Services sold out of Evolent Health (EVH) in Q1 2025, closing a stake of 19,660 shares — an estimated $221K sold.

IMA Advisory Services first reported a position in EVH in Q2 2018 and held it in 27 quarters. The position peaked at $4.23M in Q1 2021. 227 funds tracked by Wall St. Rank hold EVH as of Q1 2025.

  • IMA Advisory Services reported no remaining Evolent Health position as of Q1 2025 after selling out during the quarter.
  • IMA Advisory Services sold 19,660 Evolent Health shares in Q1 2025, an estimated $221K.
  • IMA Advisory Services first reported a position in Evolent Health in Q2 2018 and held it in 27 quarters.
  • IMA Advisory Services's Evolent Health position peaked at $4.23M in Q1 2021.
  • 227 funds tracked by Wall St. Rank held Evolent Health as of Q1 2025.

Based on IMA Advisory Services's 13F filing for Q1 2025, filed 6 May 2025.